Absorption Enhancers: Applications and Advances

被引:212
作者
Aungst, Bruce J. [1 ]
机构
[1] QPS LLC, Newark, DE 19702 USA
来源
AAPS JOURNAL | 2012年 / 14卷 / 01期
关键词
absorption; bioavailability; enhancer; permeability; TIGHT JUNCTION; INTESTINAL-ABSORPTION; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; PENETRATION ENHANCERS; ORAL ABSORPTION; CROMOLYN SODIUM; PERMEATION; PEPTIDES; PERMEABILITY;
D O I
10.1208/s12248-011-9307-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Absorption enhancers are functional excipients included in formulations to improve the absorption of a pharmacologically active drug. The term absorption enhancer usually refers to an agent whose function is to increase absorption by enhancing membrane permeation, rather than increasing solubility, so such agents are sometimes more specifically termed permeation enhancers. Absorption enhancers have been investigated for at least two decades, particularly in efforts to develop non-injection formulations for peptides, proteins, and other pharmacologically active compounds that have poor membrane permeability. While at least one product utilizing an absorption enhancer for transdermal use has reached the market, quite a few more appear to be at the threshold of becoming products, and these include oral and transmucosal applications. This paper will review some of the most advanced absorption enhancers currently in development and the formulation technologies employed that have led to their success. In addition, a more basic review of the barriers to absorption and the mechanisms by which those barriers can be surmounted is presented. Factors influencing the success of absorption-enhancing formulations are discussed. If ultimately successful, the products now in development should offer non-injection alternatives for several peptide or protein drugs currently only administered by injection. The introduction of new absorption enhancers as accepted pharmaceutical excipients, and the development of formulation technologies that afford the greatest benefit/risk ratio for their use, may create opportunities to apply these enabling technologies more broadly to existing drugs with non-optimal delivery properties.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 41 条
[1]   Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative [J].
Alani, Adam W. G. ;
Robinson, Joseph R. .
PHARMACEUTICAL RESEARCH, 2008, 25 (01) :48-54
[2]  
[Anonymous], 2008, BMC CLIN PHARM
[3]  
[Anonymous], 2011, US, Patent No. 20110014247
[4]  
Arbit Ehud, 2009, J Diabetes Sci Technol, V3, P562
[5]   Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells [J].
Arnold, JJ ;
Ahsan, F ;
Meezan, E ;
Pillion, DJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (09) :2205-2213
[6]   Reestablishment of the Nasal Permeability Barrier to Several Peptides Following Exposure to the Absorption Enhancer Tetradecyl-β-D-Maltoside [J].
Arnold, John J. ;
Fyrberg, Michael D. ;
Meezan, Elias ;
Pillion, Dennis J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (04) :1912-1920
[7]  
Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO
[8]  
2-J
[9]   CONTRIBUTIONS OF DRUG SOLUBILIZATION, PARTITIONING, BARRIER DISRUPTION, AND SOLVENT PERMEATION TO THE ENHANCEMENT OF SKIN PERMEATION OF VARIOUS COMPOUNDS WITH FATTY-ACIDS AND AMINES [J].
AUNGST, BJ ;
BLAKE, JA ;
HUSSAIN, MA .
PHARMACEUTICAL RESEARCH, 1990, 7 (07) :712-718
[10]   Enhancement of the intestinal absorption of peptides and nonpeptides [J].
Aungst, BJ ;
Saitoh, H ;
Burcham, DL ;
Huang, SM ;
Mousa, SA ;
Hussain, MA .
JOURNAL OF CONTROLLED RELEASE, 1996, 41 (1-2) :19-31